SCHEMBL22493463

SCHEMBL22493463

COc1ncccc1CCNC(C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.48
HTR2C P28335 2/20 0.48
SLC13A5 Q86YT5 3/20 0.48
KDM1A O60341 5/20 0.42
MAOA P21397 2/20 0.42
MAOB P27338 1/20 0.42
PDCD1LG2 Q9BQ51 1/20 0.39
CD274 Q9NZQ7 1/20 0.39
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
GAA P10253 1/20 0.37
APLNR P35414 1/20 0.36
SLC22A12 Q96S37 1/20 0.36
GRIN1 Q05586 1/20 0.35
GRIN2B Q13224 1/20 0.35
MTNR1A P48039 1/20 0.35
HTR2B P41595 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26854073 0.86 SLC13A5 (0.49) HTR2AHTR2CSLC13A5SLC6A2SLC6A4
SCHEMBL22493402 0.79 P2RX7 (0.37) GRIN1GRIN2B
SCHEMBL23355293 0.79 HTR2A (0.44) HTR2AHTR2CSLC13A5KDM1AMAOA
SCHEMBL12093550 0.76 SLC13A5 (0.51) HTR2AHTR2CSLC13A5KDM1AMAOA
SCHEMBL22493349 0.76 GRM5 (0.35) HTR2AHTR2CMTNR1A
SCHEMBL22493346 0.76 ALDH1A1 (0.33) HTR2AHTR2CSLC13A5MTNR1A
SCHEMBL8220219 0.76 SLC13A5 (0.48) HTR2AHTR2CSLC13A5KDM1AMAOA
SCHEMBL22493867 0.75 CD38 (0.38) GAAGRIN1GRIN2BMTNR1A
SCHEMBL22864232 0.75 HDAC6 (0.46) GAA
SCHEMBL26853974 0.75 MAPK1 (0.34) MTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020198466-A9 BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME CURASEN THERAPEUTICS, INC. (US) 2020-12-30 WO disclosed
WO-2020198466-A1 BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME CURASEN THERAPEUTICS, INC. (US) 2020-10-01 WO disclosed